Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
New Zealand · Delayed Price · Currency is NZD 44.29
-0.31 (-0.70%)
Sep 3, 2026, 4:59 PM NZST
NZE:FPH Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,308 | 2,021 | 1,743 | 1,581 | 1,682 | |
Revenue Growth | 14.22% | 15.96% | 10.23% | -5.98% | -14.69% |
Cost of Revenue | 838.3 | 750.1 | 698.4 | 642.7 | 629 |
Gross Profit | 1,470 | 1,271 | 1,044 | 938.4 | 1,053 |
Selling, General & Admin | 598.2 | 534.4 | 492.8 | 431.9 | 393.1 |
Research & Development | 235.5 | 226.9 | 198.2 | 174.3 | 154 |
Operating Expenses | 833.7 | 761.3 | 691 | 606.2 | 547.1 |
Operating Income | 636.4 | 509.6 | 353.4 | 332.2 | 505.6 |
Interest Expense | -10.3 | -11.1 | -18.2 | -6.7 | -4.9 |
Interest & Investment Income | 8.2 | 4.3 | 3.3 | 2.6 | 2.6 |
Currency Exchange Gain (Loss) | -2.8 | 0.5 | -4.7 | -0.1 | 0.9 |
EBT Excluding Unusual Items | 631.5 | 503.3 | 333.8 | 328 | 504.2 |
Asset Writedown | - | - | -98.1 | - | - |
Pretax Income | 631.5 | 503.3 | 235.7 | 328 | 504.2 |
Income Tax Expense | 163 | 126.1 | 103.1 | 77.7 | 127.3 |
Net Income | 468.5 | 377.2 | 132.6 | 250.3 | 376.9 |
Net Income to Common | 468.5 | 377.2 | 132.6 | 250.3 | 376.9 |
Net Income Growth | 24.20% | 184.47% | -47.02% | -33.59% | -28.10% |
Shares Outstanding (Basic) | 587 | 586 | 582 | 578 | 577 |
Shares Outstanding (Diluted) | 591 | 590 | 586 | 582 | 580 |
Shares Change | 0.14% | 0.69% | 0.78% | 0.28% | 0.07% |
EPS (Basic) | 0.80 | 0.64 | 0.23 | 0.43 | 0.65 |
EPS (Diluted) | 0.79 | 0.64 | 0.23 | 0.43 | 0.65 |
EPS Growth | 24.10% | 182.74% | -47.44% | -33.85% | -28.10% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 490.4 | 475 | 112.8 | 50.4 | 185.9 |
Free Cash Flow Per Share | 0.83 | 0.81 | 0.19 | 0.09 | 0.32 |
Dividend Per Share | 0.520 | 0.425 | 0.415 | 0.405 | 0.395 |
Dividend Growth | 22.35% | 2.41% | 2.47% | 2.53% | 3.95% |
Gross Margin | 63.69% | 62.89% | 59.93% | 59.35% | 62.60% |
Operating Margin | 27.57% | 25.21% | 20.28% | 21.01% | 30.06% |
Profit Margin | 20.29% | 18.66% | 7.61% | 15.83% | 22.41% |
Free Cash Flow Margin | 21.24% | 23.50% | 6.47% | 3.19% | 11.05% |
EBITDA | 759.4 | 622.5 | 444.8 | 409.5 | 578.5 |
EBITDA Margin | 32.90% | 30.80% | 25.52% | 25.90% | 34.40% |
D&A For EBITDA | 123 | 112.9 | 91.4 | 77.3 | 72.9 |
EBIT | 636.4 | 509.6 | 353.4 | 332.2 | 505.6 |
EBIT Margin | 27.57% | 25.21% | 20.28% | 21.01% | 30.06% |
Effective Tax Rate | 25.81% | 25.05% | 43.74% | 23.69% | 25.25% |